Tendonitis in Pregabalin - how severe and when it was recovered? (a real world drug study)

Summary:

We study how severe was Tendonitis, when it was recovered, drug effectiveness, race, and more among people who take Pregabalin (pregabalin). This phase IV clinical study is created by eHealthMe based on reports submitted to eHealthMe, and is updated regularly.

What is Pregabalin?

Pregabalin has active ingredients of pregabalin. It is often used in fibromyalgia. eHealthMe is studying from 74,070 Pregabalin users. Check the latest studies of Pregabalin.

What is Tendonitis?

Tendonitis (a condition that causes pain and swelling of tendons) is found to be associated with 1,098 drugs and 1,274 conditions by eHealthMe. Check the latest studies of Tendonitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 16, 2026

3 people who have Tendonitis while taking Pregabalin were studied.

Could Pregabalin cause Tendonitis?

Severity of Tendonitis *:

  • least: 0.0 %
  • moderate: 33.33 %
  • severe: 66.67 %
  • most severe: 0.0 %

When people recovered from Tendonitis *:

  • while on drug: 0.0 %
  • after off the drug: 0.0 %
  • not yet: 100 %

Effectiveness of Pregabalin *:

  • not at all: 0.0 %
  • somewhat: 0.0 %
  • moderate: 100 %
  • high: 0.0 %
  • very high: 0.0 %

Race of the people *:

  • African American, Non-Hispanic: 0.0 %
  • American Indian/Alaska Native: 0.0 %
  • Asian: 0.0 %
  • Hispanic: 0.0 %
  • Native Hawaiians/Pacific Islanders: 0.0 %
  • Two or more races: 0.0 %
  • White, Non-Hispanic: 100 %

Time on Pregabalin *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 66.67 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 33.33 %
  • 10+ years: 0.0 %

Gender of people when taking Pregabalin *:

  • female: 66.67 %
  • male: 33.33 %

Age of people when taking Pregabalin *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 33.33 %
  • 50-59: 33.33 %
  • 60+: 33.33 %

Conditions people have *:

  1. Peripheral Neuropathy (damage to nerves of the peripheral nervous system): 1 person, 33.33%
  2. Neuropathy Peripheral (surface nerve damage): 1 person, 33.33%
  3. Neuropathic Pain (pain due to nerve inflammation and damage): 1 person, 33.33%
  4. Inflammatory Pain: 1 person, 33.33%
  5. High Blood Cholesterol: 1 person, 33.33%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 33.33%
  7. Arrhythmias (irregular heartbeat): 1 person, 33.33%

Other drugs people take besides Pregabalin *:

  1. Pantoprazole: 1 person, 33.33%
  2. Naproxen: 1 person, 33.33%
  3. Ibu: 1 person, 33.33%
  4. Flecainide Acetate: 1 person, 33.33%
  5. Crestor: 1 person, 33.33%
  6. Celecoxib: 1 person, 33.33%

Other side effects people have besides Tendonitis *:

  1. Amyotrophy (muscular wasting or atrophy): 1 person, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Pregabalin and have Tendonitis?

Check whether Tendonitis is associated with a drug or a condition

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

How the study uses the data?

The study is based on pregabalin (the active ingredients of Pregabalin). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: